Solutions ยท Pharmacovigilance | Drug Safety and Risk Management | Guosa Life Sciences
Integrated Pharmacovigilance Across the Product Lifecycle
Patient safety is the foundation of responsible clinical development. As therapies become more innovative and regulatory expectations evolve, pharmacovigilance must extend beyond reporting to become a strategic function supporting informed decisions, risk management, and public confidence.
Overview
Guosa Life Sciences delivers full PV services integrating safety surveillance, medical review, regulatory reporting, risk management, and signal detection throughout the lifecycle.
Our multidisciplinary approach combines scientific expertise, regulatory knowledge, and technology-enabled processes to ensure timely safety evaluation and global compliance.
Capabilities
The GLS Advantage
Every solution delivered by Guosa Life Sciences is strengthened by the broader enterprise. Our operational teams are supported by evidence-based Insights, professional development through GLS Academy, collaborative partnerships within the Clinical Development Network, and a quality-driven delivery model, enabling scientifically sound, operationally efficient, and scalable solutions.
FAQ
Yes. Medical review, aggregate reporting, and signal detection are integral to our PV services, supported by qualified safety physicians and scientists.
Yes. Our pharmacovigilance services span the full product lifecycle, from clinical development through post-marketing surveillance.
Tell us about your objectives and our multidisciplinary team will scope an integrated, flexible solution.